San Diego-based Illumina, a global leader in genomic sequencing technology, unveiled its latest machines that could make analyzing genetics cheaper, more efficient and more accessible to researchers.

In the rapidly evolving field of genomics, sequencing technologies play a crucial role in advancing our understanding of genetic material. Among the most prominent methods are Illumina sequencing and ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Illumina, Inc. (NASDAQ:ILMN) was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF (NYSE:IJH). The provider of DNA sequencing ...

"Sequencing technology has really improved clinical outcomes in terms of risk stratification and diagnostic decisions for cancer," says Illumina bioinformatician Weida Gong. "For acute myeloid ...

Illumina is proud to be selected as sequencing technology partner to the Macrogen Consortium.

(NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies. The agreement grants Illumina access to Synaffix's patented metal-free click chemistry technology. Agreement will ...

To expand its reach in single-cell analysis and multiomics research, Illumina acquired privately-held Fluent BioSciences. The provider of DNA sequencing and array-based technologies has been in ...

BusinessWire India Bengaluru (Karnataka) [India], December 6: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today celebrated the opening of a global ...